Technology
At New Phase, we are tackling the cancer crisis with advanced treatment for cancer, that accounts for 25% of all global death cases
Standard treatments often come with severe side effects, while our novel approach offers a non-invasive and effective alternative.
By integrating nanotechnology and electromagnetic induction systems, we provide a solution that transforms metastatic cancer into a manageable disease, prolonging life, and offering hope where conventional therapies fall short.
New Phase’s Technology
By integrating nanotechnology and electromagnetic induction systems, we provide a solution that transforms metastatic cancer into a manageable disease, prolonging life, and offering hope where conventional therapies fall short.
01
Sarah Nanoparticle (SaNP)
The Sarah Nanoparticle (SaNP) represents a breakthrough in nanoparticle engineering. Our biocompatible SaNPare engineered with multi-cores of superparamagnetic iron oxide, embedded in a Phase Change Material (PCM), enhancing their heating ability in a controlled manner to destroy cancer cells while sparing healthy tissue. SaNPare intravenously administered and utilize the Enhanced Permeability and Retention (EPR) effect to selectively accumulate in cancerous tissues. Once localized, they are activated through Alternating Magnetic Field (AMF), generated by the EIS, to release controlled thermal energy, precisely inducing hyperthermia in cancer cells at 50°C.
Key Features of Sarah Nanoparticles (SaNP)
- Biocompatibility: SaNP are crafted to be safe for administration
in the human body. - Targeted Delivery: Enhanced targeting capabilities ensure
that SaNP accumulate directly in the tumor site. - Controlled Activation: Thermal energy release is meticulously controlled by using the latent heat phenomena to maximize
treatment efficacy and safety.
02
Electromagnetic Induction System (EIS)
The EIS activates the SaNP by generating a non-ionizing electromagnetic field that heats the SaNP to pre-defined temperature of 50°C causing cells destruction. The system enables targeted hyperthermia treatment within the deep tumor and metastases, without damage to healthy cells.
Electromagnetic Induction System (EIS)
- Non-Ionizing Radiation: Ensures patient’s safety by using non-ionizing radiation, guaranteeing effective treatment without damaging healthy tissues.
- Minimal Infrastructure Requirements: Designed for use in clinical settings without the need for specialized infrastructure or shielding.
How Our Treatment Works
New Phase’s approach delivers a precise, minimally invasive solution that targets metastatic cancer.
Regulation and Safety
Designated as a Class III medical device, our technology meets the highest safety and regulatory standards, reflecting its advanced design and safety profile. We are working in close collaboration with the FDA and the Israeli Ministry of Health, as we advance through clinical trials.
Certifications
New Phase operates under ISO 13485:2016 certification. SaNPare manufactured on site in a clean-room (grade A-C) environment, ensuring the highest quality standards in production for clinical use.
